Adcock Ingram Integrated Report 2018

24 ADCOCK INGRAM  Integrated Report 2018 Operational review (continued) PRESCRIPTION ADISHA SINGH Financial Director ASHLEY PEARCE Managing Director Turnover R2 238m (2017: R1 938m) Top 10 brands turnover R803m Trading profit R239m (2017: R208m) Volume market position #2 Value market position #3 Value market share 7.0% Volume market share 10.9% MARKET SHARE (1) ARV private market share 16.6% 320 factory and laboratory 212 sales, marketing and administration 126 in Genop NUMBER OF EMPLOYEES TOP BRANDS Trivenz Genpayne Adco-Zolpidem Myprodol Topzole Synaleve Estrofem Urizone Xylotox MANUFACTURING Capacity per annum 6 million ℓ Oral liquids 500 tonnes Creams/Ointments 2 billion Tablets and capsules Accreditations South Africa (SAHPRA), Ghana (FDB), Malawi (PMPB), Kenya (PPB), Zimbabwe (MCAZ), and Botswana (DRU). (1) IQVIA MAT Jun 2018, including MNC partnerships Location Wadeville 88% 12% Sales Private (SEP) Public (tender) OUR PERFORMANCE